Annals of the Rheumatic Diseases - Google Scholar Metrics

h5-index:121
h5-median:174

h5-index is the h-index for articles published in the last 5 complete years. It is the largest number h such that h articles published in 2014-2018 have at least h citations each.hide

h5-median for a publication is the median number of citations for the articles that make up its h5-index.hide

#1 Rheumatology

Title / Author	Cited by	Year
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update JS Smolen, R Landewé, FC Breedveld, M Buch, G Burmester, ... Annals of the Rheumatic Diseases 73 (3), 492-509	2057	2014
The global burden of neck pain: estimates from the Global Burden of Disease 2010 study D Hoy, L March, A Woolf, F Blyth, P Brooks, E Smith, T Vos, J Barendregt, ... Annals of the Rheumatic Diseases 73 (7), 1309-1315	1450	2014
The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study M Cross, E Smith, D Hoy, S Nolte, I Ackerman, M Fransen, L Bridgett, ... Annals of the Rheumatic Diseases 73 (7), 1323-1330	1182	2014
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the Rheumatic Diseases 76 (6), 960-977	1047	2017
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force JS Smolen, FC Breedveld, GR Burmester, V Bykerk, M Dougados, ... Annals of the Rheumatic Diseases 75 (1), 3-15	640	2016
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update L Gossec, JS Smolen, S Ramiro, M de Wit, M Cutolo, M Dougados, ... Annals of the Rheumatic Diseases 75 (3), 499-510	497	2016
2016 updated EULAR evidence-based recommendations for the management of gout P Richette, M Doherty, E Pascual, V Barskova, F Becce, ... Annals of the Rheumatic Diseases 76 (1), 29-42	491	2017
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA) M Dougados, M Soubrier, A Antunez, P Balint, A Balsa, MH Buch, ... Annals of the Rheumatic Diseases 73 (1), 62-68	453	2014
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study JG Coghlan, CP Denton, E Grünig, D Bonderman, O Distler, D Khanna, ... Annals of the Rheumatic Diseases 73 (7), 1340-1349	443	2014
2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative T Neogi, L Tim, N Dalbeth, J Fransen, HR Schumacher, D Berendsen, ... Annals of the Rheumatic Diseases 74 (10), 1789-1798	418	2015
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts CH Shiboski, SC Shiboski, R Seror, LA Criswell, M Labetoulle, ... Annals of the Rheumatic Diseases 76 (1), 9-16	400	2017
The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study M Cross, E Smith, D Hoy, L Carmona, F Wolfe, T Vos, B Williams, ... Annals of the Rheumatic Diseases 73 (7), 1316-1322	397	2014
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force JS Smolen, J Braun, M Dougados, P Emery, O FitzGerald, P Helliwell, ... Annals of the Rheumatic Diseases 73 (1), 6-16	393	2014
Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial C Ritchlin, P Rahman, A Kavanaugh, IB McInnes, L Puig, S Li, Y Wang, ... Annals of the Rheumatic Diseases 73 (6), 990-999	387	2014
The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis C Roubille, V Richer, T Starnino, C McCourt, A McFarlane, P Fleming, ... Annals of the Rheumatic Diseases 74 (3), 480-489	356	2015
Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA) PJ Mease, R Fleischmann, AA Deodhar, J Wollenhaupt, M Khraishi, ... Annals of the Rheumatic Diseases 73 (1), 48-55	356	2014
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis D van der Heijde, S Ramiro, R Landewé, X Baraliakos, F Van den Bosch, ... Annals of the Rheumatic Diseases 76 (6), 978-991	353	2017
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial IB McInnes, J Sieper, J Braun, P Emery, D van der Heijde, JD Isaacs, ... Annals of the Rheumatic Diseases 73 (2), 349-356	349	2014
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis M Yates, RA Watts, IM Bajema, MC Cid, B Crestani, T Hauser, B Hellmich, ... Annals of the Rheumatic Diseases 75 (9), 1583-1594	341	2016
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update R Agca, SC Heslinga, S Rollefstad, M Heslinga, IB McInnes, MJL Peters, ... Annals of the Rheumatic Diseases 76 (1), 17-28	340	2017

1 - 20

Dates and citation counts are estimated and are determined automatically by a computer program.